• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Tuesday 07/17/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

HedgePath

  • 2:33 PM

    Funds raised will support ongoing Phase II(b) clinical trial in Basal Cell Carcinoma Nevus Syndrome, an orphan cancer hereditary disease requiring life-long therapy with no approved pharmaceutical treatment License and Manufacturing Partner Mayne Pharma invests $2.8MM PR Newswire TAMPA, Fla. and SAN DIEGO, June 1, 2016 TAMPA, Fla. and SAN DIEGO, June 1, 2016 /PRNewswire/ — HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced

    Read more
  • 11:37 AM

    Red Mountain Resources http://www.Publicwire.com (PublicWire.com Press Release) — Dallas, TX –, Jan 29, 2014 (GLOBE NEWSWIRE via COMTEX) — Red Mountain Resources, Inc. (OTCQB: RDMP.QB) (the “Company”) announced today that effective at 12:01 a.m. Eastern Time on January 31, 2014, the Company will effect a 1-for-10 reverse split of its shares of common stock (the “Reverse Split”). Beginning with the opening of trading on January 31, 2014, the Company’s common stock will continue to trade on the OTCBB on a

    Read more
Public Wire Banner